Omeros (OMER) Enterprise Value (2010 - 2026)
Omeros' (OMER) quarterly Enterprise Value came in at -$135.3 million in Q1 2026, down 158.18% year-on-year from $232.6 million in Q1 2025, and up 21.24% quarter-over-quarter from -$171.8 million in Q4 2025.
Omeros (OMER) Enterprise Value (2010 - 2026) Analysis & Trends
Omeros has disclosed Enterprise Value across 17 years of filings, most recently posting -$135.3 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$135.3 million, down 158.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$135.3 million (down 158.18% YoY), and the FY2025 annual result was -$171.8 million, down 90.61% from the prior year.
- Enterprise Value came in at -$135.3 million for Q1 2026 at Omeros, up from -$171.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$36.1 million in Q3 2025 to a low of -$458.8 million in Q1 2024.
- The 5-year median for Enterprise Value is -$194.9 million (2022), against an average of -$214.4 million.
- Across the five-year window, Enterprise Value sank 488.48% in 2022 and surged 88.58% in 2025, its largest moves.
- Omeros' Enterprise Value stood at -$194.9 million in 2022, then grew by 11.84% to -$171.8 million in 2023, then surged by 47.55% to -$90.1 million in 2024, then slumped by 90.61% to -$171.8 million in 2025, then rose by 21.24% to -$135.3 million in 2026.
- The last three Enterprise Value figures came in at -$135.3 million (Q1 2026), -$171.8 million (Q4 2025), and -$36.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | -135.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.32 Mn |
| Dec 31, 2025 | -171.80 Mn |
| Sep 30, 2025 | -36.09 Mn |
| Jun 30, 2025 | -55.54 Mn |
| Mar 31, 2025 | -52.41 Mn |
| Dec 31, 2024 | -90.13 Mn |
| Sep 30, 2024 | -244.84 Mn |
| Jun 30, 2024 | -315.69 Mn |
| Mar 31, 2024 | -458.80 Mn |
| Dec 31, 2023 | -171.85 Mn |
| Sep 30, 2023 | -310.31 Mn |
| Jun 30, 2023 | -341.28 Mn |
| Mar 31, 2023 | -371.33 Mn |
| Dec 31, 2022 | -194.92 Mn |
| Sep 30, 2022 | -296.43 Mn |
| Jun 30, 2022 | -122.53 Mn |
| Mar 31, 2022 | -275.47 Mn |
| Dec 31, 2021 | -157.27 Mn |
| Sep 30, 2021 | -50.37 Mn |
| Jun 30, 2021 | -73.66 Mn |